Announce Date | 04/23/2025 |
EPS Normalized Actual | $1.7 (Miss by $-0.06) |
EPS GAAP Actual | $1.7 (Miss by $-0.06) |
Revenue Actual | $3.621B |
Revenue Surprise | Beat by $3621M |
Announce Date | 06/30/2025 (Pre-Market) |
EPS Normalized Estimate | $3.04 |
EPS GAAP Estimate | $3.04 |
Revenue Estimate | $4.231B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2029 | 17.8 | 4.5 | 17.33237 | 18.40407 | 1 |
Dec 2028 | 22.75 | 3.52 | 22.07528 | 24.85156 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 1.29 | -1.255 | 3.621B | -24% | -130.5M |
FQ4 2024 (Dec 2024) | 0 | 0 | 4.136B | -23.02% | 4136M |
FQ3 2024 (Sep 2024) | 0 | 0 | 3.993B | -23.37% | 3993M |
FQ2 2024 (Jun 2024) | 3.99 | 3.99 | 3.989B | -20.13% | 3989M |
FQ1 2024 (Mar 2024) | 0 | 0 | 4.49B | -3.54% | 4490M |
FQ4 2023 (Dec 2023) | 0 | 0 | 5.088B | 3.24% | 5088M |
FQ3 2023 (Sep 2023) | 1.53 | 1.53 | 4.926B | 2.88% | 4926M |
FQ2 2023 (Jun 2023) | 1.56 | 1.56 | 4.792B | -6.36% | 4792M |
FQ4 Announce Date
06/30/2025 (Pre-Market)
Consensus EPS Estimates
3.04
Consensus Revenue Estimates
4.231B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 3.0432 | -- | 2.96492 | 3.09891 | 1 |
FQ2 2027 (Jun 2027) | 2.4026 | -- | 2.3408 | 2.44658 | 1 |
FQ1 2027 (Mar 2027) | 2.0393 | -- | 1.98685 | 2.07663 | 1 |
FQ4 2026 (Oct 2026) | 3.4358 | -- | 3.32693 | 3.56059 | 1 |
FQ3 2026 (Jul 2026) | 2.0607 | -- | 1.9954 | 2.13555 | 1 |
FQ2 2026 (Jun 2026) | 2.5412 | -- | 2.40764 | 2.65064 | 1 |
FQ1 2026 (Mar 2026) | 2.5795 | 49.99 | 2.44393 | 2.69059 | 1 |
FQ4 2025 (Oct 2025) | 3.865 | -- | 3.74252 | 4.00538 | 2 |
FQ3 2025 (Jul 2025) | 2.78 | -- | 2.69191 | 2.88097 | 2 |
FQ2 2025 (Jun 2025) | 3.04 | -31.25 | 2.91526 | 3.26272 | 2 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 4.04B | -- | 3.96B | 4.1B | 2 |
FQ2 2027 (Jun 2027) | 4.05B | -- | 3.97B | 4.11B | 2 |
FQ1 2027 (Mar 2027) | 4.06B | -- | 3.98B | 4.12B | 1 |
FQ4 2026 (Oct 2026) | 4.4B | -- | 4.29B | 4.52B | 2 |
FQ3 2026 (Jul 2026) | 4.4B | -- | 4.3B | 4.53B | 2 |
FQ2 2026 (Jun 2026) | 3.92B | -- | 3.76B | 4.05B | 2 |
FQ1 2026 (Mar 2026) | 3.93B | 7.87 | 3.77B | 4.06B | 2 |
FQ4 2025 (Oct 2025) | 4.19B | 1.38 | 4.09B | 4.31B | 1 |
FQ3 2025 (Jul 2025) | 4.15B | 3.8 | 4.05B | 4.27B | 1 |
FQ2 2025 (Jun 2025) | 4.23B | 5.72 | 4.1B | 4.47B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
1
EPS # of in-lines
4
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.545 | 1.29 | -1.255 | -97.29% |
FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
FQ2 2024 (Jun 2024) | 3.99 | 3.99 | 100% | |
FQ1 2024 (Mar 2024) | 0 | 0 | NAN% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 1.53 | 1.53 | 100% | |
FQ2 2023 (Jun 2023) | 1.56 | 1.56 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $3.75B | $3.62B | $-130.5M | -3.6% |
FQ4 2024 (Dec 2024) | $0B | $4.14B | $4136M | 100% |
FQ3 2024 (Sep 2024) | $0B | $3.99B | $3993M | 100% |
FQ2 2024 (Jun 2024) | $0B | $3.99B | $3989M | 100% |
FQ1 2024 (Mar 2024) | $0B | $4.49B | $4490M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.09B | $5088M | 100% |
FQ3 2023 (Sep 2023) | $0B | $4.93B | $4926M | 100% |
FQ2 2023 (Jun 2023) | $0B | $4.79B | $4792M | 100% |